Advances in Subretinal Gene Therapy for the Treatment of nAMD

Author(s)/Faculty: Nancy M. Holekamp, MD; Allen C. Ho, MD
Release Date: 7/15/2022Expiration Date: 7/14/2023
Credit Type: CME / CME with ABO Continuing Certification Number of Credits: 0.25
Content Type: VideoProvider:
In this Expert Exchange, Drs. Holekamp and Ho discuss advances in subretinal gene therapy for the treatment of neovascular age-related macular degeneration (nAMD).